Clinical Trial Update: Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib in combination with chemotherapy for soft tissue sarcoma is ongoing with status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN